CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet

CARGO Therapeutics to Participate in Upcoming Investor Conferences CARGO Therapeutics to Participate in Upcoming Investor Conferences

CARGO Therapeutics Announces Pricing of Initial Public Offering CARGO Therapeutics Announce Pricing of IPO

Sorrento Receives FDA Clearance to Start Clinical Trial of Anti-CD47 Antibody, Discovered from Fully Human G-MAB Library, for Treatment of Multiple Malignancies Internally developed fully human anti-CD47 antibody (STI-6643) cleared for basket trial;No complicated titration or priming dose of the antibody is required to reduce toxicity;This study will be...